Jan 12, 2021 / 03:00PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Good morning, everyone. My name is Jess Fye. I'm one of the senior biotech analysts at JPMorgan. And we're continuing the 2021 Healthcare Conference this morning with Denali. I'm joined by the company's CEO, Ryan Watts. And before we get started, I just wanted to let you know that you can use the blue Ask a Question button on the webcast to send questions into a portal. And I could ask them to management once we move to Q&A after Ryan's done presenting. So with that out of the way, let me turn it over to you, Ryan.
Ryan J. Watts - Denali Therapeutics Inc. - Co-Founder, President, CEO & Director
Excellent. Thank you, Jess. Good morning. Great to be here with everyone. Very excited to share with you the progress we've made at Denali over the past year and what we see for the future of Denali, it's a very exciting time. Just a reminder that this is a user-advanced slide deck. So I will be highlighting the slide numbers occasionally in the bottom left-hand corner, especially
Denali Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot